Medical/Pharmaceuticals

Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology

SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of anbenitamab injection (KN026), independently developed by the ...

2026-01-27 09:58 6805

ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low-Friction TPU

HSINCHU, Jan. 27, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation inWHX Dubai 2026 (formerly Arab Health), taking place from 9 to 12 February at the Dubai ...

2026-01-27 09:17 9872

New "MedTech Advance" Sourcing Directory Launches to Streamline Global Medical Device Manufacturing

Comprehensive e-book accelerates product development by connecting R&D and procurement teams with global suppliers. TAICHUNG, Jan. 27, 2026 /PRNewswire/ -- Today marks the official release of  MedTech Advance, a comprehensive digital buyer's directory engineered to accelerate the sourcing process...

2026-01-27 09:00 4169

Functional Medicine Malaysia: Emagene Life Academy Officially Launches with Successful "Good Gut Gathering" Workshop

KUALA LUMPUR, Malaysia, Jan. 26, 2026 /PRNewswire/ -- Emagene Life <>, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of functional medicine education in the region. The Academy's lau...

2026-01-27 00:37 6547

Gu Sheng Tang Donates S$1.06 Million to NTU Singapore to Advance Traditional Chinese Medicine Research and Education in Singapore

SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM and Nanyang Technological University, Singapore (NTU Singapore) officially launched theGu Sheng Tang Traditional Chinese Medicine Education and Research Programme today. As part ...

2026-01-26 18:00 5636

WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline

SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and auto...

2026-01-26 17:35 16456

Get Exclusive Limited-Edition Gifts During Your Lunar New Year Trip: Wakamoto Launches "Thank You from Wakamoto" Campaign

TOKYO, Jan. 26, 2026 /PRNewswire/ -- Wakamoto Pharmaceutical Co., Ltd. (Tokyo, Arata Igarashi), a company dedicated to supporting healthy and active lifestyles, will launch a nationwide campaign in which customers who purchase "Strong Wakamoto" will receive an original hand towel.

2026-01-26 13:00 5676

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

-Topline data from the Phase II study for the treatment of diabetes are  expected in the third quarter of 2026. -ASC30 demonstrated placebo-adjusted weight loss of up to 7.7% in a recently completed 13-week U.S. Phase II study in participants with obesity or o verweight, withbetter gastrointestina...

2026-01-26 08:10 10547

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and Drug Administration (FDA). The agency's Master ...

2026-01-26 08:00 6940

Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026

DUBAI, UAE, Jan. 23, 2026 /PRNewswire/ -- Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution atWHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58). Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," Ozelle will highlight how dia...

2026-01-23 18:00 8058

Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation

SHENZHEN, China, Jan. 22, 2026 /PRNewswire/ -- May Li, Board Secretary of Mindray Medical (300760.SZ), delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference (JPM Conference) on January 15, 2026, outlining the company's strategic vision for the next decade centered on three core...

2026-01-22 22:11 17595

pixelRo to Showcase AI-Powered Digital Healthcare and Air Sterilization Solutions at CES 2026 and WHX Dubai

SEOUL, South Korea, Jan. 22. 2026 /PRNewswire/ -- pixelRo, a Samsung Electronics spin-off digital healthcare company, is accelerating its global expansion by participating in CES 2026 and WHX Dubai 2026 (formerly Arab Health). pixelRo develops and operates AI-based integrated self-diagnostic kio...

2026-01-22 16:59 5001

BTL Announces Successful Enforcement of Patent Rights Relating to EMFACE® Against WonderFace Device

PRAGUE, Jan. 22, 2026 /PRNewswire/ -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. ("Lexter"), the manufacturer of the WonderFace device. The settl...

2026-01-22 16:00 5226

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

* Positioning Telangana among the world's top five life sciences clusters by 2030 * Targets USD 25 billion in investments * Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ -- The Government of Telangana, India tod...

2026-01-22 09:00 6980

TraceLink Marks Five Years of Sustained Global Impact Through Corporate Grant Program

From pandemic response to long-term community investment, TraceLink's corporate grants have supported 60 nonprofit organizations worldwide Summary From 2020 through 2025, TraceLink's corporate grant program supported 60 nonprofit organizations worldwide, advancing healthcare access, food security...

2026-01-21 23:00 6842

Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System

Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 /PRNewswire/ -- Trisol Medical, a clinical-stage medical device company developing a ...

2026-01-21 21:55 8273

DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation

WASHINGTON, Jan. 21, 2026 /PRNewswire/ -- The Drug Information Association (DIA) today announced the launch ofDIA ASCENT , a new global platform designed to support early-stag...

2026-01-21 21:39 5769

Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology

* Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines TORONTO, Jan. 21, 2026 /PRNewswire/ -- Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters ...

2026-01-21 21:00 6962

Sisram Medical Partners with Sinmait Medical Technology to Build Next-Generation Manufacturing and Innovation Hub in China

HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced th...

2026-01-21 19:08 14799

HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services

SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research institute focused on conducting clinical trials in hepatology a...

2026-01-21 11:00 5835
1 ... 38394041424344 ... 385

Week's Top Stories